Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00651924 · ClinicalTrials.gov registry record · NA

Piloting IVR (Interactive Voice Response) for Chronic Pain Treatment

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT00651924: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00651924 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00651924, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

This study is designed to develop and test the use of Interactive Voice Response (IVR) technology to deliver pain management treatment. IVR allows individuals to receive and provide information by using their touchtone telephone. This will allow more people with chronic pain to receive treatment even if they are not able to drive to an appointment regularly. In the first part of the study, the investigators will develop new materials like patient handbooks and pre-recorded explanations about common pain control techniques. In the second part of the study, a small number of persons with chronic pain will receive treatment using the new materials. We will ask for their feedback about how well they liked using the new materials and if the materials are understandable. This will allow us to revise the materials if we need to prior to studying them with a larger group of people with chronic pain.

Primary Outcome

Each treatment session had 5 True / False questions that corresponded with the material in the patient handbook. Phase 1 participants reviewed individual treatment modules in the patient handbook to provide immediate feedback regarding how understandable, engaging, and informative they find the materials. Phase 2 participants' used the patient materials as part of treatment and the true/false questions were used to evaluate comprehension of the materials. Example questions: Chronic pain can affe

Interventions

  • BEHAVIORAL IVR-based Cognitive-behavior therapy

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-12
Est. Completion 2009-04
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00651924 record still lists

NCT00651924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which IVR-based Cognitive-behavior therapy is the first listed.

NCT00651924 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00651924 about?

NCT00651924 is a clinical study titled "Piloting IVR (Interactive Voice Response) for Chronic Pain Treatment". This study is designed to develop and test the use of Interactive Voice Response (IVR) technology to deliver pain management treatment. IVR allows individuals to receive and provide information by using their touchtone telephone. This will allow more people with chronic pain to receive treatment eve...

What is the current status of trial NCT00651924?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2008-12. Estimated completion is 2009-04.

What interventions are being tested in trial NCT00651924?

The interventions under investigation include: IVR-based Cognitive-behavior therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00651924?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00651924's enrollment target sits among peer trials

27 1708th of 2000 higher than 291 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00651924, the US trial registry maintained by the National Library of Medicine. NCT00651924 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.